| Metric | Q1'26 | Q2'26 | Change |
|---|---|---|---|
| Adjusted EBITDA (quarter) | $4.9B, vs $4.1B in Q1'25 | $5.1B, vs $3.9B in Q2'25 | Sequential +$200M, y/y growth accelerating |
| DCF (quarter) | $2.7B, vs $2.3B Q1'25 | $2.6B, vs $2.0B Q2'25 | Sequential DECLINE despite EBITDA rising |
| FY26 Adj EBITDA guidance | $18.2-18.6B midpoint $18.4B | $18.8-19.1B midpoint $18.95B | Midpoint increased $550M, from $18.4B to $18.95B |
| FY26 growth capex guidance | $5.5-5.9B | $5.6-5.9B | Floor raised $100M, range narrowed to top end |
| H1 organic capex spend | Q1 alone: $1.5B | H1 total: $2.6B, implying ~$1.1B in Q2 | Implied H2 spend $3.0B-$3.3B, about 15%-27% above H1, on the stated comparable scope |
| NGL & Refined Products EBITDA | $1.2B | $1.3B, vs $1.0B Q2'25 | Sequential growth, driven by $212M premium/margin pickup |
| Midstream EBITDA | $887M, down from $925M Q1'25 | $884M, up from $768M Q2'25 | Flat sequentially; year-over-year growth is not a guidance beat |
| Crude Oil EBITDA | $869M | $834M, vs $732M Q2'25 | Sequential decline of $35M |
| Interstate EBITDA | $519M | $481M | Sequential decline of $38M |
| Intrastate EBITDA | $437M, incl $100M one-time winter storm | $377M, incl $113M basis differential + $17M Hugh Brinson commissioning | Sequential decline of $60M; basis and commissioning drivers require separate recurrence analysis |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.